Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESTRO 2022 | The importance of Patient Reported Outcomes in clinical trials

Pedro Lara • 16 May 2022
ESTRO 2022
General

Pedro Lara, MD, PhD, Fernando Pessoa Canarias University and San Roque University Hospital, Gran Canarias, Spain, emphasises the importance of focusing on patient experiences and opinions in clinical trials. Prof. Lara also discusses how to make it easier for patients to submit Patient Reported Outcomes (PROs), such as using apps. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.

More from Pedro Lara

1:43
How can we optimise the use of patient reported outcomes in clinical practice?
Pedro Lara • 16 May 2022
1:01
Highlights in breast and gynecological cancer at ESTRO 2022
Pedro Lara • 17 May 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals